Navigation Links
Cornerstone Therapeutics Inc. Stockholders Seeking More Money Regarding the Proposed Buyout by Chiesi Farmaceutici S.P.A. Encouraged to Contact Lawyers at Deans & Lyons
Date:10/19/2013

DALLAS, Oct. 18, 2013 /PRNewswire/ -- Securities lawyers at Deans & Lyons announced a class action against the board of Cornerstone Therapeutics Inc. (NASDAQ: CRTX) in connection with a buyout for $9.50 per share. Concerned CRTX investors should contact attorney Hamilton Lindley at 877-819-8033 or hlindley@deanslyons.com about their rights and remedies.

"Chiesi Farmaceutici has been a controlling shareholder since 2009 and currently owns 58% of Cornerstone stock. Yahoo! Finance has valued Cornerstone above the deal price consistently for the past month," said securities lawyer Hamilton Lindley. "Our potential shareholder lawsuit will seek to ensure that all relevant information is disclosed and that the Cornerstone Therapeutics Inc. shareholders receive the highest price reasonably available for their stock." 

Deans & Lyons has significant experience representing shareholders in securities lawsuits nationwide.  CRTX stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@deanslyons.com or 877-819-8033 with questions or concerns.

Hamilton Lindley
DEANS & LYONS LLP
325 North Saint Paul Street, Suite 1500
Dallas, TX 75201
Phone: 214-736-7861
Fax: 214-965-8505
Toll-free: 877-819-8033
hlindley@deanslyons.com
www.deanslyons.com


'/>"/>
SOURCE Deans & Lyons, LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Stipulation Of Dismissal Of Claims By Plaintiff Cornerstone Biopharma, Inc.
2. Mast Therapeutics To Present At The 12th Annual BIO Investor Forum On October 8
3. Mast Therapeutics To Present At The Leerink Swann Rare Disease Roundtable On October 2
4. Aratana Therapeutics to Present at BioCenturys NewsMakers in the Biotech Industry Conference
5. Healthpoint Biotherapeutics To Assume Smith & Nephew Name
6. PTC Therapeutics to Present at World Muscle Society Congress
7. MabVax Therapeutics Receives $1,750,000 Small Business Innovation Research Contract Award From The National Cancer Institute To Support Development of Novel Pancreatic Cancer Diagnostic Imaging Agent
8. Chrysalis BioTherapeutics, Inc., Receives $1.5m from the National Cancer Institute to Mitigate Radiotherapy-Induced Brain Tissue Damage
9. Halozyme Therapeutics To Present At The BioCentury Newsmakers In The Biotech Industry Conference
10. Cell Therapeutics Announces Closing of Sale of Convertible Preferred Stock
11. Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):